Exact Mass: 195.2092
Exact Mass Matches: 195.2092
Found 79 metabolites which its exact mass value is equals to given mass value 195.2092,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
2,5-Dibutyl-4-methyloxazole
2,5-Dibutyl-4-methyloxazole is found in cocoa and cocoa products. 2,5-Dibutyl-4-methyloxazole is a constituent of cocoa butter. Constituent of cocoa butter. 2,5-Dibutyl-4-methyloxazole is found in cocoa and cocoa products.
5-Ethyl-2-hexyl-4-methyloxazole
5-Ethyl-2-hexyl-4-methyloxazole is found in potato. 5-Ethyl-2-hexyl-4-methyloxazole is a volatile constituent of French fried potato. Volatile constituent of French fried potato. 5-Ethyl-2-hexyl-4-methyloxazole is found in potato.
4-Methyl-2-pentyl-5-propyloxazole
Not reported in nature. Not reported in nature
4-Ethyl-2-hexyl-5-methyloxazole
Not reported in nature. Not reported in nature
4,5-Dimethyl-2-heptyloxazole
Not reported in nature. Not reported in nature
1-Amino-3-hydroxymethyl-5-methyl-adamantane
1-Amino-3-hydroxymethyl-5-methyl-adamantane is a metabolite of memantine. Memantine is the first in a novel class of Alzheimers disease medications acting on the glutamatergic system by blocking NMDA glutamate receptors. It was first synthesized by Eli Lilly and Company in 1968. Memantine is marketed under the brands Axura and Akatinol by Merz, Namenda by Forest, Ebixa and Abixa by Lundbeck and Memox by Unipharm. Despite years of research, there is little evidence of effect in mild to moderate Alzheimers disease. (Wikipedia)
3-Amino-1-hydroxy-5,7-dimethyl-adamantane
3-Amino-1-hydroxy-5,7-dimethyl-adamantane is a metabolite of memantine. Memantine is the first in a novel class of Alzheimers disease medications acting on the glutamatergic system by blocking NMDA glutamate receptors. It was first synthesized by Eli Lilly and Company in 1968. Memantine is marketed under the brands Axura and Akatinol by Merz, Namenda by Forest, Ebixa and Abixa by Lundbeck and Memox by Unipharm. Despite years of research, there is little evidence of effect in mild to moderate Alzheimers disease. (Wikipedia)
1,2,3,5,6,8a-Hexahydro-alpha-propyl-8-indolizinemethanol
(3R,5S,7aS)-3-methyl-5-pentylhexahydro-1H-pyrrolizine
(2S,6S)-2,6-DIISOPROPYL-2,3,5,6-TETRAHYDRO-1H-IMIDAZO[1,2-A]IMIDAZOLE
Tricyclo[3.3.1.13,7]decane-1-MethanaMine, N-hydroxy-α-Methyl-
1-Amino-3-hydroxymethyl-5-methyl-adamantane
1-Amino-3-hydroxymethyl-5-methyl-adamantane is a metabolite of memantine. Memantine is the first in a novel class of Alzheimers disease medications acting on the glutamatergic system by blocking NMDA glutamate receptors. It was first synthesized by Eli Lilly and Company in 1968. Memantine is marketed under the brands Axura and Akatinol by Merz, Namenda by Forest, Ebixa and Abixa by Lundbeck and Memox by Unipharm. Despite years of research, there is little evidence of effect in mild to moderate Alzheimers disease. (Wikipedia)
